organophosphonates has been researched along with Ache in 17 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (47.06) | 29.6817 |
2010's | 8 (47.06) | 24.3611 |
2020's | 1 (5.88) | 2.80 |
Authors | Studies |
---|---|
Bagheri, R; Das, T; Erfani, M; Noorvand, M; Saniei, E; Shirmardi, SP | 1 |
Becker, C; Hamnvik, OP; Vaidya, A | 1 |
Afarideh, H; Vaez-Tehrani, M; Yousefnia, H; Zolghadri, S | 1 |
Aslangul, E; Caillat-Vigneron, N; Le Jeunne, C; Perrot, S; Szwebel, T | 1 |
Bauer, I; Freynhagen, R; Hermanns, H; Kollosche, K; Lipfert, P; Muth-Selbach, U; Stegmann, JU | 1 |
Banerjee, S; Chakraborty, S; Das, T; Pillai, MR; Sarma, HD; Tandon, P; Venkatesh, M | 1 |
León, E; Lozano de León-Naranjo, F; Pérez-Rivera, AÁ; Sáez, P | 1 |
Ikegami, T; Kato, M; Kawate, H; Maehara, Y; Nomura, M; Sakamoto, R; Soejima, Y; Takayanagi, R; Taketomi, A; Watanabe, T | 1 |
Ahmad, M; Jehangir, M; Perveen, A; Sohaib, M | 1 |
Hao, JG; Hou, XC; Li, SK; Xu, J; Yan, XB; Zhou, PP | 1 |
Agu, KA; Akpoigbe, KJ; Badru, T; Chabikuli, O; Eluwa, GI; Hamelmann, C | 1 |
Abdou, WM; Barghash, RF; Bekheit, MS | 1 |
Banerjee, S; Chakraborty, S; Das, T; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Venkatesh, M | 1 |
Banerjee, S; Chakraborty, S; Das, T; Mathew, B; Pillai, MR; Samuel, G; Sarma, HD; Venkatesh, M | 1 |
Imming, P | 1 |
da Fonseca Pacheco, CM; da Fonseca Pacheco, D; de Castro Perez, A; de Francischi, JN; Duarte, ID; Klein, A | 1 |
Banerjee, S; Chaudhari, PR; Kothari, K; Pillai, MR; Samuel, G; Sarma, HD; Unni, PR; Unnikrishnan, TP | 1 |
17 other study(ies) available for organophosphonates and Ache
Article | Year |
---|---|
Internal dosimetry studies of
Topics: Animals; Bone Neoplasms; Computer Simulation; Humans; Mice; Models, Animal; Organometallic Compounds; Organophosphonates; Pain; Pain Management; Palliative Care; Radioisotopes; Radiometry; Radiopharmaceuticals; Radiotherapy Dosage; Radiotherapy Planning, Computer-Assisted; Rats; Thulium; Tissue Distribution | 2020 |
Interactive medical case: wasting away.
Topics: Adenine; Adult; Bone Density; Electrolytes; Fanconi Syndrome; Female; Hepatitis B, Chronic; Humans; Hypokalemia; Nausea; Organophosphonates; Osteomalacia; Pain; Reverse Transcriptase Inhibitors; Tenofovir | 2014 |
Human absorbed dose estimation for a new (175)Yb-phosphonate based on rats data: Comparison with similar bone pain palliation agents.
Topics: Animals; Bone Neoplasms; Humans; Organophosphonates; Pain; Pain Management; Radiation Dosage; Rats; Tissue Distribution; Ytterbium | 2016 |
Bone pain due to fractures revealing osteomalacia related to tenofovir-induced proximal renal tubular dysfunction in a human immunodeficiency virus-infected patient.
Topics: Adenine; Bone Density Conservation Agents; Fanconi Syndrome; Female; Fractures, Bone; HIV Infections; Humans; Middle Aged; Organophosphonates; Osteomalacia; Pain; Reverse Transcriptase Inhibitors; Tenofovir | 2009 |
Antinociceptive effects of systemic lidocaine: involvement of the spinal glycinergic system.
Topics: Analgesics; Animals; Binding Sites; Glycine; Glycine Agents; Lidocaine; Organophosphonates; Pain; Quinoxalines; Rats; Receptors, N-Methyl-D-Aspartate; Serine; Spinal Cord; Substrate Specificity; Synaptic Transmission | 2009 |
(170)Tm-EDTMP: a potential cost-effective alternative to (89)SrCl(2) for bone pain palliation.
Topics: Animals; Bone and Bones; Organometallic Compounds; Organophosphonates; Pain; Palliative Care; Radioisotopes; Radiometry; Radionuclide Imaging; Rats; Rats, Wistar; Strontium; Thulium; Tissue Distribution | 2009 |
[HIV infected women with intense bone and muscular pain and general weakness].
Topics: Adenine; Alkynes; Anti-HIV Agents; Benzoxazines; Cyclopropanes; Deoxycytidine; Drug Therapy, Combination; Emtricitabine; Fanconi Syndrome; Female; Hepatitis, Viral, Human; HIV Infections; Humans; Hypophosphatemia; Middle Aged; Muscle Weakness; Musculoskeletal Diseases; Organophosphonates; Osteomalacia; Pain; Radionuclide Imaging; Radiopharmaceuticals; Substance Abuse, Intravenous; Technetium Tc 99m Medronate; Tenofovir | 2011 |
Hypophosphatemic osteomalacia as a long-term complication after liver transplantation.
Topics: Adenine; Aged; Fanconi Syndrome; Female; Humans; Hypophosphatemia; Immunosuppressive Agents; Liver Transplantation; Male; Middle Aged; Organophosphonates; Osteomalacia; Pain; Phosphates; Quality of Life; Treatment Outcome; Vitamin D | 2011 |
Ethylene diamine tetramethylene phosphonic acid labeled with various β(-)-emitting radiometals: labeling optimization and animal biodistribution.
Topics: Animals; Beta Particles; Bone and Bones; Bone Marrow; Isotope Labeling; Male; Metals, Rare Earth; Organometallic Compounds; Organophosphonates; Organophosphorus Compounds; Pain; Palliative Care; Radionuclide Imaging; Radiopharmaceuticals; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2011 |
[A case with poly-bone pain, decrease of bone density and in crease of serum creatinine related to adefovir dipivoxil treatment in a chronic hepatitis B patient].
Topics: Adenine; Adult; Bone Density; Creatinine; Hepatitis B, Chronic; Humans; Male; Organophosphonates; Pain; Phosphorus | 2011 |
Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
Topics: Adenine; Adolescent; Adult; Alkynes; Anti-Retroviral Agents; Benzoxazines; Cohort Studies; Cyclopropanes; Drug-Related Side Effects and Adverse Reactions; Exanthema; Female; HIV Infections; Humans; Incidence; Lamivudine; Male; Middle Aged; Nevirapine; Nigeria; Organophosphonates; Pain; Retrospective Studies; Risk Factors; Stavudine; Tenofovir; Zidovudine | 2012 |
Carbodiimides in the synthesis of enamino- and α-aminophosphonates as peptidomimetics of analgesic/antiinflammatory and anticancer agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carbodiimides; Cell Line, Tumor; Disease Models, Animal; Drug Stability; Humans; Inflammation; Male; Mice; Neoplasms; Organophosphonates; Pain; Peptidomimetics; Structure-Activity Relationship | 2012 |
177Lu-labeled cyclic polyaminophosphonates as potential agents for bone pain palliation.
Topics: Animals; Bone Neoplasms; Heterocyclic Compounds, 1-Ring; Lutetium; Organophosphonates; Organophosphorus Compounds; Pain; Palliative Care; Radioisotopes; Radiopharmaceuticals; Rats; Rats, Wistar; Tissue Distribution | 2002 |
175Yb labeled polyaminophosphonates as potential agents for bone pain palliation.
Topics: Animals; Bone and Bones; Bone Neoplasms; Hydrogen-Ion Concentration; Organophosphonates; Pain; Palliative Care; Radiopharmaceuticals; Rats; Rats, Wistar; Spectrometry, Gamma; Tissue Distribution; Ytterbium | 2004 |
Fatty pain cures.
Topics: Amidohydrolases; Analgesics; Animals; Arachidonic Acids; Biphenyl Compounds; Brain; Cannabinoid Receptor Agonists; Cannabinoid Receptor Modulators; Endocannabinoids; Enzyme Inhibitors; Glycerides; Humans; Monoacylglycerol Lipases; Organophosphonates; Pain; Polyunsaturated Alkamides; Rats; Receptors, Cannabinoid | 2007 |
The mu-opioid receptor agonist morphine, but not agonists at delta- or kappa-opioid receptors, induces peripheral antinociception mediated by cannabinoid receptors.
Topics: Amidohydrolases; Analgesics, Opioid; Animals; Arachidonic Acids; Benzamides; Benzomorphans; Cannabinoid Receptor Modulators; Dinoprostone; Disease Models, Animal; Dose-Response Relationship, Drug; Enzyme Inhibitors; Hyperalgesia; Indoles; Male; Morphine; Organophosphonates; Pain; Pain Measurement; Piperazines; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu | 2008 |
186Re-1,4,8,11-tetraaza cyclotetradecyl-1,4,8,11-tetramethylene phosphonic acid: a novel agent for possible use in metastatic bone-pain palliation.
Topics: Analgesics; Animals; Bone Neoplasms; Etidronic Acid; Heterocyclic Compounds, 1-Ring; Injections, Intravenous; Male; Organometallic Compounds; Organophosphonates; Pain; Rabbits; Rats; Rats, Sprague-Dawley; Rhenium; Tissue Distribution | 2001 |